Dyslipidemias Trials in Cincinnati, United States
Conditions / Dyslipidemias / Cincinnati, United States
Clinical trials for Dyslipidemias investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04753606 | Randomized Study of Obicetrapib as an Adjunct to Statin Therapy | COMPLETED | PHASE2 |
| NCT01435382 | A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia | COMPLETED | PHASE1 |
| NCT00639158 | Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood | COMPLETED | PHASE3 |
| NCT00477594 | Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia | COMPLETED | PHASE2 |
| NCT00694109 | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia | COMPLETED | PHASE3 |
| NCT05266586 | Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy | COMPLETED | PHASE2 |
| NCT03097107 | Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL | SUSPENDED | PHASE2 |
| NCT00607373 | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia | COMPLETED | PHASE3 |
| NCT04516291 | A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) | COMPLETED | PHASE2 |
| NCT06005597 | Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies | COMPLETED | PHASE3 |